TheraRadar
← Back
Data updated: Jul 17, 2026

COOK IMAGING

Generics
Pharmaceuticals

COOK IMAGING is a generic drug manufacturer with 4 FDA-approved products.

2000
Since
4
Drugs
-
Trials
0
New Drugs (2yr)

COOK IMAGING's Key Drugs

COOK IMAGING's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

COOK IMAGING's Recent FDA Approvals

New NDA/BLA approvals for COOK IMAGING over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

COOK IMAGING's Therapeutic Areas

Disease areas where COOK IMAGING has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

COOK IMAGING Pipeline Snapshot

Active clinical trials for COOK IMAGING across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling